Opinion

Video

Treatment and Patient Reported Outcomes in Atopic Dermatitis

Christopher Bunick, MD, PhD, examines patient satisfaction upon achieving primary study endpoints in clinical trials and highlights the significance of patient-reported outcomes (PROs) in both clinical trial designs and patient care.

  1. In clinic, how satisfied are patients who have met primary study endpoints that were examined in clinical trials.
    • What do you hear from patients?
  2. How important is incorporation of patient reported outcomes (PRO) in clinical trial designs and their use in patient care?

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Steven Fein, MD | Credit: University of Michigan
© 2024 MJH Life Sciences

All rights reserved.